发明名称 Swallowable capsule and method for stimulating incretin production within the intestinal tract
摘要 Embodiments of the invention provide apparatus and methods for stimulating L cells in the intestinal tract to produce incretins for the treatment of conditions including diabetes and obesity. Many embodiments provide a method and apparatus for the treatment of diabetes by electrically stimulating L-cells to secrete incretins to stimulate or otherwise modulate the production of insulin. Particular embodiments provide a swallowable capsule for stimulating L-cells in the intestinal tract as the capsule moves through the tract. The capsule can include two or more electrodes for providing electrical stimulation to L-cells, a power source for powering one or more components of the capsule, a sensor for sensing the location of the capsule in the intestinal tract; a controller and a waveform generator for generating the electrical signals emitted by the electrodes to stimulate the L-cells to secrete incretins such as GLP-1 to stimulate insulin production for glucose regulation of diabetic conditions.
申请公布号 US8781591(B2) 申请公布日期 2014.07.15
申请号 US201414179215 申请日期 2014.02.12
申请人 Incube Labs, LLC 发明人 Imran Mir A.;Hashim Mir;Arnsdorf Emily
分类号 A61N1/06;A61N1/05;A61N1/36 主分类号 A61N1/06
代理机构 代理人
主权项 1. A method for stimulating L-cells in an intestinal track of a patient to secrete a polypeptide, the method comprising: ingesting a swallowable device configured to travel through the intestinal tract and electrically stimulate the L-cells at any location in the intestinal tract; delivering an electrical signal from the device to an intestinal wall proximate the device, wherein the signal includes a waveform configured to electrically stimulate the L-cells in the intestinal tract to secrete the polypeptide without substantially causing a peristaltic contraction.
地址 San Jose CA US